Noble Roman’s Inc. (OTCMKTS:NROM – Get Free Report) was the target of a large growth in short interest during the month of October. As of October 15th, there was short interest totaling 4,728 shares. Currently, 0.0% of the company’s shares are short sold. Based on an average daily trading volume, of 33,123 shares, the short-interest ratio is presently 0.1 days.
Noble Roman’s Trading Up 1.7%
Shares of NROM stock traded up $0.01 during trading on Friday, hitting $0.61. 13,750 shares of the stock traded hands, compared to its average volume of 12,994. Noble Roman’s has a 52-week low of $0.16 and a 52-week high of $0.77. The firm has a market capitalization of $13.85 million, a P/E ratio of 12.20 and a beta of 0.12. The firm’s fifty day moving average price is $0.60 and its 200-day moving average price is $0.47. The company has a debt-to-equity ratio of 1.39, a current ratio of 1.33 and a quick ratio of 0.97.
Noble Roman’s (OTCMKTS:NROM – Get Free Report) last issued its quarterly earnings data on Wednesday, August 12th. The company reported $0.01 earnings per share for the quarter. The company had revenue of $4.12 million during the quarter. Noble Roman’s had a return on equity of 30.64% and a net margin of 6.58%.
About Noble Roman’s
Noble Roman’s, Inc is a restaurant franchising and licensing company headquartered in Indianapolis, Indiana. Founded in 1972, the company develops and supports foodservice concepts centered on pizza and Italian-American menu items.
The company’s primary brands include Noble Roman’s Pizza and Tuscano’s Italian Style Subs. Its menu offerings generally include pizza, specialty pizzas, submarine sandwiches, breadsticks, salads and related products. Noble Roman’s concepts are offered through both traditional restaurants and nontraditional locations, including convenience stores, travel plazas, universities, hospitals, hotels and other institutional or high-traffic venues.
Noble Roman’s provides franchisees and licensees with brand support, operating systems, recipes, training and related services.
Further Reading
- Five stocks we like better than Noble Roman’s
- Eli Lilly’s First Full Medicare Quarter: Is Volume Still Outrunning Price Cuts?
- Oracle’s AI Spending Peak Is in Sight—Can the Stock Recover?
- LyondellBasell’s Dividend Looks Safer, But a New Risk Could Change That
- L3Harris Stock Took a Beating—Is a 20% Rebound Next?
Receive News & Ratings for Noble Roman's Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Noble Roman's and related companies with MarketBeat.com's FREE daily email newsletter.
